Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning
NCT ID: NCT06312839
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2024-04-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome was the efficacy of preoperative ischemic conditioning in preventing anastomotic leakage, assessed through CT scans. Secondary outcomes included analyzing safety of ischemic gastric conditioning, hypertrophy of the gastroepiploic artery in embolized patients and comparing hospital stay length and postoperative mortality.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ischemic Conditioning of the Gastric Conduit in Esophageal Cancer.
NCT04268654
Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer
NCT06097078
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
NCT03115541
Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy
NCT04162860
Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation
NCT06348381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Esophagectomy alone
Collecting data from the medical record
Collecting data from the medical record:
* Gastroepiploic artery diameter before and after ischaemic preconditioning
* Postoperative mortality
* Complications related to embolisation and surgery
* Length of stay in intensive care unit and total length of hospital stay
Study Group
Preoperative ischemic conditioning before esophagectomy
Collecting data from the medical record
Collecting data from the medical record:
* Gastroepiploic artery diameter before and after ischaemic preconditioning
* Postoperative mortality
* Complications related to embolisation and surgery
* Length of stay in intensive care unit and total length of hospital stay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collecting data from the medical record
Collecting data from the medical record:
* Gastroepiploic artery diameter before and after ischaemic preconditioning
* Postoperative mortality
* Complications related to embolisation and surgery
* Length of stay in intensive care unit and total length of hospital stay
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rémi GRANGE, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Priest-en-Jarez, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rémi Grange, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN032024/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.